ArticleNew microbes and new infections2026
Assessing the burden of diabetes mellitus in dengue patients: A systematic review and meta-analysis.
Article in New microbes and new infections, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Dengue is a rapidly expanding mosquito-borne viral disease and a growing global public health challenge. Simultaneously, the prevalence of diabetes mellitus (DM) continues to rise worldwide. DM, often referred to as a silent pandemic, is characterized by chronic inflammation, endothelial dysfunction, and impaired immune responses, mechanisms that may worsen dengue outcomes. Objectives: Given this context, our study aimed to systematically synthesize evidence on the association between DM and severe dengue outcomes, especially severe dengue and dengue-related mortality. Methods: PubMed, Scopus, and Embase were searched, alongside manual screening of reference lists, for English-language observational studies published between 1987 and 2025 reporting dengue outcomes in patients with and without DM. Severe dengue definitions based on both WHO 1997 and WHO 2009 classifications were considered. Screening, data extraction, and risk-of-bias assessment were performed independently by two reviewers, with disagreements resolved by consensus. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were estimated using random-effects models. Results: A total of 27 eligible studies involving 734,123 participants met the inclusion criteria. Compared with non-diabetic patients, those with DM had significantly higher odds of severe dengue (OR: 2.66, 95% CI: 1.90-3.73) and of dengue-related mortality (OR: 3.95, 95% CI: 2.98-5.23). Conclusions: DM is independently associated with severe dengue and dengue-related mortality. These findings underscore the need for early identification and close monitoring of diabetic patients in dengue-endemic settings, and for integrated management strategies addressing both infectious and non-communicable diseases. Further research is needed to elucidate the underlying mechanisms and evaluate targeted interventions in this vulnerable population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.